Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 3631 AL 3645

Insulin in brain: The physiological functions and therapeutic insights for neurodegenerative diseases

Shang X, Chen SY, Zhang XY, Regina I, Zhang T, Luo J, Yan YZ, Qiao-yuanYao, Tong F, Pan LH.

Life Sci. 2026 Aug 1;398:124468. doi: 10.1016/j.lfs.2026.124468. Epub 2026 May 15.

Lithium as a disease-modifying therapy for Parkinson's disease: mechanisms, preclinical evidence, and clinical prospects

Boonstra JT.

Clin Park Relat Disord. 2026 Apr 9;14:100440. doi: 10.1016/j.prdoa.2026.100440. eCollection 2026.

Therapeutic and Diagnostic Implications of Carbon Dot: An Advancement in the Avenue towards Cancer, Diabetes and Neurodegenerative Disorders

Manna S, Banerjee S, De A, Banerjee S, Das S, Rakshit P, S K AK, Sen KK, De S.

Pharm Nanotechnol. 2026;14(1):94-121. doi: 10.2174/0122117385314533240824090949.

Machine learning to diagnose, classify and predict phenoconversion in isolated REM sleep behavior disorder

Raheel K, Sheybani L, Biabani N, Rui SQ, Delogu A, Rosenzweig J, Cvetkovic Z, Leech R, Grossman N, Tahmasian M, Goadsby PJ, Chaudhuri KR, Schenck CH, Rosenzweig I.

Sleep Med Rev. 2026 Apr 29;88:102298. doi: 10.1016/j.smrv.2026.102298. Online ahead of print.

Targeting TLR4 in Parkinson's disease: mechanisms and therapeutic prospects

Dong S, Lu J, Wu L, Wang S, Gong Y, Hu J, Liu Y, Chen X.

Int Immunopharmacol. 2026 Aug 1;182:116780. doi: 10.1016/j.intimp.2026.116780. Epub 2026 May 6.

Parkinson's through a cultural lens: Diversity in disease expression and care

Morales-Briceno H, Chen KS, Becker P, Williams L, Paramanandam V, Toh TS, Ojo O, Sassi SB, Aldaajani Z, Tan AH.

J Parkinsons Dis. 2026 May 12:1877718X261440706. doi: 10.1177/1877718X261440706. Online ahead of print.

PINK1/Parkin-dependent mitophagy mediates astrocytic inflammatory responses to mitochondrial damage

Riley JF, Robbins CV, Holzbaur ELF.

bioRxiv [Preprint]. 2026 May 13:2026.05.11.724378. doi: 10.64898/2026.05.11.724378.

The Microbiota-Gut-Brain Axis Across the Lifespan: From Neurodevelopment to Neurodegeneration

Carnazzo SM, Fanos V.

J Clin Med. 2026 Apr 17;15(8):3065. doi: 10.3390/jcm15083065.

Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's disease

Foltynie T, Gandhi S, Carroll C.

J Parkinsons Dis. 2026 Feb 8:1877718X261420002. doi: 10.1177/1877718X261420002. Online ahead of print.

Cueing-assisted gamified augmented-reality home rehabilitation for gait and balance in people with Parkinson disease: feasibility and effectiveness in the clinical pathway

Hoogendoorn EM, Geerse DJ, van Dam AT, van Hall SJ, van Doorn PF, Hardeman LES, Hoozemans MJM, Stins JF, Roerdink M.

Phys Ther. 2026 Mar 3;106(3):pzag012. doi: 10.1093/ptj/pzag012.

Flavonoids improve neurotransmitters for Parkinson's treatment: mechanism and therapeutic potential

Zhang Y, Bu Y, Song M, Hao Z, Chen J.

Front Pharmacol. 2026 Apr 9;17:1799142. doi: 10.3389/fphar.2026.1799142. eCollection 2026.

Iron dyshomeostasis in neuropsychiatric disorders

Cheng M, Ma J, Yang Y, Cao M, Zhang E, Feng B, Wang Q, Du Z.

Front Psychiatry. 2026 Apr 21;17:1771423. doi: 10.3389/fpsyt.2026.1771423. eCollection 2026.

Parkinson's disease drug therapies in the clinical trial pipeline: 2015-2024

Buff S, Pilcicka A, Pitzer K, Fiske B, Stott SR, McFarthing K.

J Parkinsons Dis. 2026 May 26:1877718X261454154. doi: 10.1177/1877718X261454154. Online ahead of print.

Advancing the Treatment of Motor Fluctuations in Parkinson's Disease with a Next-Generation Levodopa/Carbidopa Formulation

Stocchi F, Knecht M, Marjanovic I, Wach A, Kopra J, Kulisevsky J.

Neurol Ther. 2026 Jun;15(3):829-842. doi: 10.1007/s40120-026-00898-z. Epub 2026 Feb 22.

Neuroinflammation and Oxidative Stress in Parkinson's Disease, Alzheimer's Disease, and COVID-19: Microglia-Neutrophil Interaction

de Araújo AB, S Azul FVC, Carneiro YC, de Sousa CNS, de Vasconcelos SMM, Rios FJ, Leal LKAM.

ACS Omega. 2026 Jan 26;11(5):6922-6938. doi: 10.1021/acsomega.5c10397. eCollection 2026 Feb 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias